DLD Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-38,436
| Closed | -$3.74M | – | 56 |
|
|
2023
Q1 | $3.74M | Buy |
38,436
+21,706
| +130% | +$2.11M | 0.31% | 50 |
|
|
2022
Q4 | $1.73M | Buy |
16,730
+4,000
| +31% | +$414K | 0.15% | 61 |
|
|
2022
Q3 | $1.08M | Buy |
12,730
+530
| +4% | +$44.9K | 0.08% | 78 |
|
|
2022
Q2 | $1.01M | Buy |
+12,200
| New | +$1.01M | 0.07% | 78 |
|
|
2021
Q2 | – | Sell |
-38,300
| Closed | -$2.89M | – | 115 |
|
|
2021
Q1 | $2.89M | Buy |
+38,300
| New | +$2.89M | 0.08% | 66 |
|
|
2020
Q2 | – | Sell |
-23,720
| Closed | -$2M | – | 49 |
|
|
2020
Q1 | $2M | Buy |
23,720
+720
| +3% | +$60.8K | 0.13% | 48 |
|
|
2019
Q4 | $1.95M | Buy |
23,000
+200
| +0.9% | +$16.9K | 0.1% | 45 |
|
|
2019
Q3 | $1.54M | Sell |
22,800
-4,500
| -16% | -$303K | 0.08% | 43 |
|
|
2019
Q2 | $2.34M | Sell |
27,300
-6,100
| -18% | -$522K | 0.1% | 47 |
|
|
2019
Q1 | $2.97M | Buy |
33,400
+23,000
| +221% | +$2.04M | 0.11% | 45 |
|
|
2018
Q4 | $886K | Buy |
+10,400
| New | +$886K | 0.06% | 52 |
|